BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen XP, Lau WY, Huang ZY, Zhang ZW, Chen YF, Zhang WG, Qiu FZ. Extent of liver resection for hilar cholangiocarcinoma. Br J Surg. 2009;96:1167-1175. [PMID: 19705374 DOI: 10.1002/bjs.6618] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Franken LC, Schreuder AM, Roos E, van Dieren S, Busch OR, Besselink MG, van Gulik TM. Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis. Surgery. 2019;165:918-928. [PMID: 30871811 DOI: 10.1016/j.surg.2019.01.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
2 Hartog H, Ijzermans JN, van Gulik TM, Koerkamp BG. Resection of Perihilar Cholangiocarcinoma. Surgical Clinics of North America 2016;96:247-67. [DOI: 10.1016/j.suc.2015.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
3 Fisher AV, Ronnekleiv-kelly SM. Surgical Management of Hilar Cholangiocarcinoma. Curr Surg Rep 2018;6. [DOI: 10.1007/s40137-018-0210-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Lu J, Li B, Li FY, Ye H, Xiong XZ, Cheng NS. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated? Eur J Surg Oncol 2019;45:2173-9. [PMID: 31208772 DOI: 10.1016/j.ejso.2019.06.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Abdelwahab M, El Nakeeb A, Salah T, Hamed H, Ali M, El Sorogy M, Shehta A, Ezatt H, Sultan AM, Zalata K. Hilar cholangiocarcinoma in cirrhotic liver: a case-control study. Int J Surg. 2014;12:762-767. [PMID: 24909136 DOI: 10.1016/j.ijsu.2014.05.058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Bhardwaj N, Garcea G, Dennison AR, Maddern GJ. The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg 2015;39:2748-56. [PMID: 26133907 DOI: 10.1007/s00268-015-3125-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
7 Blaga MM, Brasoveanu V, Stroescu C, Ionescu M, Popescu I, Dumitrascu T. Pattern of the First Recurrence Has No Impact on Long-Term Survival after Curative Intent Surgery for Perihilar Cholangiocarcinomas. Gastroenterol Res Pract 2018;2018:2546257. [PMID: 30158963 DOI: 10.1155/2018/2546257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Safarpour AR, Askari H, Ejtehadi F, Azarnezhad A, Raeis-Abdollahi E, Tajbakhsh A, Abazari MF, Tarkesh F, Shamsaeefar A, Niknam R, Sivandzadeh GR, Lankarani KB, Ejtehadi F. Cholangiocarcinoma and liver transplantation: What we know so far? World J Gastrointest Pathophysiol 2021; 12(5): 84-105 [PMID: 34676129 DOI: 10.4291/wjgp.v12.i5.84] [Reference Citation Analysis]
9 Singh MK, Facciuto ME. Current management of cholangiocarcinoma. Mt Sinai J Med. 2012;79:232-245. [PMID: 22499494 DOI: 10.1002/msj.21298] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
10 Regimbeau JM, Fuks D, Le Treut YP, Bachellier P, Belghiti J, Boudjema K, Baulieux J, Pruvot FR, Cherqui D, Farges O; AFC-HC study group. Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group. J Gastrointest Surg. 2011;15:480-488. [PMID: 21249527 DOI: 10.1007/s11605-011-1414-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
11 Sun DX, Tan XD, Gao F, Xu J, Cui DX, Dai XW. Use of an autologous liver round ligament flap zeros postoperative bile leak after curative resection of hilar cholangiocarcinoma. PLoS One 2015;10:e0125977. [PMID: 25938440 DOI: 10.1371/journal.pone.0125977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Xu X, Yang L, Chen W, He M. Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes. J Int Med Res 2021;49:3000605211008336. [PMID: 33983055 DOI: 10.1177/03000605211008336] [Reference Citation Analysis]
13 Liang L, Li C, Jia HD, Diao YK, Xing H, Pawlik TM, Lau WY, Shen F, Huang DS, Zhang CW, Yang T. Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies. Ther Adv Gastrointest Endosc 2021;14:2631774521993065. [PMID: 33629062 DOI: 10.1177/2631774521993065] [Reference Citation Analysis]
14 Yang H, Xiang S, Lau WY, Huang Z, Luo H, Cheng Q, Chen L, Wang H, Wang G, Chen X. A new cholangiojejunostomy for multiple biliary ductal openings: A study in pigs. International Journal of Surgery 2015;22:15-21. [DOI: 10.1016/j.ijsu.2015.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Yu H, Wu SD, Chen DX, Zhu G. Laparoscopic resection of Bismuth type I and II hilar cholangiocarcinoma: an audit of 14 cases from two institutions. Dig Surg. 2011;28:44-49. [PMID: 21293131 DOI: 10.1159/000322398] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
16 Zheng-rong L, Hai-bo Y, Xin C, Chuan-xin W, Zuo-jin L, Bing T, Jian-ping G, Sheng-wei L. Resection and Drainage of Hilar Cholangiocarcinoma: An 11-Year Experience of a Single Center in Mainland China. The American Surgeon 2011;77:627-33. [DOI: 10.1177/000313481107700525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
17 Yang H, Tang J, Peng X, Zhang S, Sun H, Lv H, Li J, Chen X. Treatment of complicated hepatic cystic hydatidosis with intrabiliary rupture by pericystectomy in combination with Roux-en-Y hepaticojejunostomy. J Huazhong Univ Sci Technol [Med Sci ] 2012;32:205-9. [DOI: 10.1007/s11596-012-0036-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Ota Y, Matsuyama R, Taniguchi K, Ueda M, Takeda K, Tanaka K, Nakayama T, Endo I. Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a case. Clin J Gastroenterol 2013;6:485-9. [PMID: 24319501 DOI: 10.1007/s12328-013-0432-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
20 Groot Koerkamp B, Wiggers JK, Allen PJ, Besselink MG, Blumgart LH, Busch OR, Coelen RJ, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, Jarnagin WR, van Gulik TM. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. J Am Coll Surg. 2015;221:1041-1049. [PMID: 26454735 DOI: 10.1016/j.jamcollsurg.2015.09.005] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 10.3] [Reference Citation Analysis]
21 Wong M, Kim J, George B, Eriksen C, Pearson T, Robbins J, Zimmerman MA, Hong JC. Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study.J Surg Res. 2019;242:23-30. [PMID: 31059945 DOI: 10.1016/j.jss.2019.04.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 Zaydfudim VM, Rosen CB, Nagorney DM. Hilar cholangiocarcinoma. Surg Oncol Clin N Am 2014;23:247-63. [PMID: 24560109 DOI: 10.1016/j.soc.2013.10.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 72] [Article Influence: 3.8] [Reference Citation Analysis]
23 Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Ohge H, Sueda T. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 2011;18:651-8. [PMID: 20945107 DOI: 10.1245/s10434-010-1325-4] [Cited by in Crossref: 143] [Cited by in F6Publishing: 128] [Article Influence: 11.9] [Reference Citation Analysis]
24 Hu HJ, Zhou RX, Shrestha A, Tan YQ, Ma WJ, Yang Q, Lu J, Wang JK, Zhou Y, Li FY. Relationship of tumor size with pathological and prognostic factors for hilar cholangiocarcinoma. Oncotarget 2017;8:105011-9. [PMID: 29285229 DOI: 10.18632/oncotarget.22054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Yu H, Wu SD, Tian Y, Su Y, Li YN. Single-incision laparoscopic resection of Bismuth I hilar cholangiocarcinoma. Surg Innov 2013;20:209-13. [PMID: 22393076 DOI: 10.1177/1553350612438414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
26 Jingdong L, Yongfu X, Yang G, Jian X, Xujian H, Jianhua L, Wenxing Z, Renyi Q, Xinming Y, Shuguo Z, Xiao L, Bin P, Qifan Z, Dewei L, Zhao-Hui T. Minimally invasive surgery for hilar cholangiocarcinoma: a multicenter retrospective analysis of 158 patients. Surg Endosc 2020. [PMID: 33258033 DOI: 10.1007/s00464-020-08161-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Edwin B, Nordin A, Kazaryan AM. Laparoscopic liver surgery: new frontiers. Scand J Surg 2011;100:54-65. [PMID: 21482506 DOI: 10.1177/145749691110000110] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
28 Tang Z, Yang Y, Zhao Z, Wei K, Meng W, Li X. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e11999. [PMID: 30142840 DOI: 10.1097/MD.0000000000011999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
29 Gumbs AA, Jarufe N, Gayet B. Minimally invasive approaches to extrapancreatic cholangiocarcinoma. Surg Endosc 2013;27:406-14. [PMID: 22926892 DOI: 10.1007/s00464-012-2489-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
30 Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis. 2015;30:159-171. [PMID: 25376337 DOI: 10.1007/s00384-014-2063-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
31 Bird NTE, McKenna A, Dodd J, Poston G, Jones R, Malik H. Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma. Br J Surg. 2018;105:1408-1416. [PMID: 29999515 DOI: 10.1002/bjs.10921] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
32 Hwang S. Standard and modified techniques for parenchyma-preserving hepatectomy focused on segments I+IV resection in patients with perihilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2021;25:112-21. [PMID: 33649263 DOI: 10.14701/ahbps.2021.25.1.112] [Reference Citation Analysis]
33 van Gulik TM, Ruys AT, Busch OR, Rauws EA, Gouma DJ. Extent of Liver Resection for Hilar Cholangiocarcinoma (Klatskin Tumor): How Much Is Enough? Dig Surg 2011;28:141-7. [DOI: 10.1159/000323825] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
34 Hoyos S, Navas MC, Restrepo JC, Botero RC. Current controversies in cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1461-1467. [PMID: 28756216 DOI: 10.1016/j.bbadis.2017.07.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
35 Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg. 2011;212:514-20; discussion 520-1. [PMID: 21463781 DOI: 10.1016/j.jamcollsurg.2010.12.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
36 Cao Y, Dai CL, Xu F. Advances in understanding the mechanisms of impaired hepatic regeneration in patients with obstructive jaundice. Shijie Huaren Xiaohua Zazhi 2010; 18(30): 3210-3214 [DOI: 10.11569/wcjd.v18.i30.3210] [Reference Citation Analysis]
37 Patyutko YI, Polyakov AN, Podluzhnyi DV, Syskova AY, Sagaidak IV, Kotel'nikov AG, Sergeeva ON, Pokataev IA. [Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment]. Khirurgiia (Mosk) 2018;:30-7. [PMID: 30560842 DOI: 10.17116/hirurgia201812130] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Boudjema K, Levi Sandri GB, Boucher E, Rohou T, Rayar M, Sulpice L. An update on liver surgery for cholangiocarcinoma. Updates Surg 2014;66:93-100. [DOI: 10.1007/s13304-013-0235-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 Regimbeau JM, Fuks D, Bachellier P, Le Treut YP, Pruvot FR, Navarro F, Chiche L, Farges O. Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group. Eur J Surg Oncol. 2011;37:505-512. [PMID: 21514090 DOI: 10.1016/j.ejso.2011.03.135] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
40 Sapisochin G, Ivanics T, Subramanian V, Doyle M, Heimbach JK, Hong JC. Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: A review of the general principles. Int J Surg 2020;82S:77-81. [PMID: 32380231 DOI: 10.1016/j.ijsu.2020.04.067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Lau SH, Lau WY. Current therapy of hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2012;11:12-7. [PMID: 22251465 DOI: 10.1016/s1499-3872(11)60119-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
42 Wang SF, Huang ZY, Chen XP. Biliary complications after living donor liver transplantation. Liver Transpl. 2011;17:1127-1136. [PMID: 21761548 DOI: 10.1002/lt.22381] [Cited by in Crossref: 79] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
43 Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc. 2009;41:4023-4035. [PMID: 20005336 DOI: 10.1016/j.transproceed.2009.11.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
44 Spaggiari M, Mashbari H, Di Bella C, Benedetti E, Tzvetanov I. Portojejunostomy in Split Liver Transplantation as a Rescue Technique for Challenging Biliary Reconstruction: A Case Report. Transplant Proc 2019;51:575-8. [PMID: 30879593 DOI: 10.1016/j.transproceed.2018.12.017] [Reference Citation Analysis]
45 Li QJ, Zhou ZG, Lin XJ, Lao XM, Cui BK, Li SP. Clinical practice of basin-shaped hepaticojejunostomy following hilar resection of stage III/IV hilar cholangiocarcinoma. BMC Gastroenterol 2019;19:99. [PMID: 31221103 DOI: 10.1186/s12876-019-1012-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N, Vella I, De Carlis L. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers (Basel) 2021;13:3657. [PMID: 34359560 DOI: 10.3390/cancers13153657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kimbrough CW, Cloyd JM, Pawlik TM. Surgical approaches for the treatment of perihilar cholangiocarcinoma. Expert Review of Anticancer Therapy 2018;18:673-83. [DOI: 10.1080/14737140.2018.1473039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
48 Mocan T, Horhat A, Mois E, Graur F, Tefas C, Craciun R, Nenu I, Spârchez M, Sparchez Z. Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how? World J Gastrointest Oncol 2021; 13(12): 2050-2063 [DOI: 10.4251/wjgo.v13.i12.2050] [Reference Citation Analysis]
49 Ramos E. Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol 2013; 5(7): 139-146 [PMID: 23919108 DOI: 10.4251/wjgo.v5.i7.139] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]